Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, biomarkers, and other cancer treatments, will be highlighted at the American ...

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

"We have discovered a molecular switch that can revert the fate of cancer cells," said biologist Kwang-Hyun Cho.

Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

Traditionally, chemotherapy was given after surgery (primary cytoreductive surgery (PCRS) and adjuvant chemotherapy). However, chemotherapy can be used before surgery (neoadjuvant chemotherapy (NACT) ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.

Cancer cases in Jammu and Kashmir have increased by 50 percent at Paras Health Srinagar from September 2023 to January 2025, ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...

I had a high-flying job that involved a lot of stress and little sleep – until a cancer diagnosis made me turn my life around ...

Huntsman Cancer Institute at the University of Utah (the U) proudly announces the addition of two da Vinci 5 robotic surgical systems.